Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 5.00
Ask: 5.50
Change: 0.00 (0.00%)
Spread: 0.50 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.25
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Apr 2021 07:00

RNS Number : 2155V
Totally PLC
13 April 2021
 

Certain information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

13 April 2021

Totally plc

("Totally", the "Company" or the "Group")

Trading update

The Board of Totally plc (AIM: TLY), a leading provider of a range of healthcare services across the UK, today announces an update on trading for the 12-month period ended 31 March 2021.

 

Excellent trading performance

Based on draft unaudited numbers, the Group anticipates reporting EBITDA* for the year ended 31 March 2021 substantially ahead of both management expectations and the historic underlying EBITDA of £4.0 million reported by the Group in the financial year ended 31 March 2020. The resilient and improved trading performance across the Group is due to multiple factors but primarily as a result of the Company being able to respond proactively and quickly to the numerous demands for its healthcare services during the global COVID-19 pandemic, through which the Company has assisted the NHS in providing frontline care across the UK. The Directors would like to put on record their thanks for the services provided by their own frontline employees, the NHS and every healthcare organisation the Group works with.

 

As at 31 March 2021 the Company was in a healthy financial position with £14.8 million of net cash (31 March 2020: £8.9 million). The Company has no debt financing ** and all deferred HMRC payments have been paid in full.

 

Agile and quick response

Against the backdrop of a global pandemic, the year to 31 March 2021 was undoubtedly one of the most challenging periods of time for the Company. Through effective management, however, the emergency preparedness and response was quickly and efficiently executed. 

 

All operations of the Group were impacted with some services, particularly face-to-face, understandably paused. However, with the increased demand for urgent healthcare support, the Group was well placed to respond quickly through, among others, the delivery of COVID-19 Management Services, National Clinical Assessment Services and the ramping up of 111 capacity.

 

Strong market position

Totally continues to make strong progress with its stated strategy of delivering a range of quality healthcare services across the UK and Ireland in partnership with the NHS and other healthcare providers. Over the course of the 12-month period the Group announced numerous contract renewals and new business models being delivered, many targeted to manage demand during the pandemic, which amounted to an aggregate contract value of c. £92.5m. The Group was also pleased at the end of March 2021 to be chosen as a qualified provider to Yorkshire Ambulance Service NHS Trust, the first agreement that Totally has entered into under the new NHS Integrated Care System framework.

 

Totally saw positive movement in its Care Quality Commission (CQC) ratings, resulting in all of its registered services now being rated as "Good". These activities and successes have placed the Group in a strong position as a preferred partner of the NHS.

 

The Directors also note that waiting lists across the UK have all increased during the last year as a result of elective care being paused during the COVID-19 period. The Group's insourcing division continues to be appointed by numerous hospitals across the UK and Ireland to provide services to help reduce these waiting lists. The Directors therefore anticipate significant growth for the insourcing division of the Group in the short term. The Group's Planned Care division has also resumed services during the past few months, mobilising new dermatology services across Manchester and physiotherapy services to a number of police forces in the south-west of England.

 

Patient and staff wellbeing remains the Group's top priority as it continues to deliver critical front-line services across the UK and Ireland.

 

Financial Results for the 12-month period ended 31 March 2021

 

The Directors expect the Company to release its audited final results for the 12-month period ended 31 March 2021 in July 2021. The Directors expect to re-introduce market guidance at the time of the final results.

 

* EBITDA is defined as earnings before interest, tax, depreciation and amortisation and excludes one-off exceptional items.

 

** Following the adoption of IFRS 16, the Company has reported operating lease commitments as a debt on its balance sheet however these do not affect the day to day working capital available to the Group.

For further information please contact:

 

Totally plc 

020 3866 3330

Wendy Lawrence, Chief Executive

Bob Holt, Chairman

 

Allenby Capital Limited (Nominated Adviser & Joint Corporate Broker)

020 3328 5656

Nick Athanas / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales & Corporate Broking)

 

Canaccord Genuity Limited (Joint Corporate Broker)

020 7523 8000

Bobbie Hilliam

Alex Aylen

 

Yellow Jersey PR

020 3004 9512

Joe Burgess, Henry Wilkinson

 

 

Notes to Editors

Totally plc is a leading healthcare service provider in the UK and Ireland, working in partnership with the NHS and other providers to deliver healthcare services through its divisions of Urgent Care, Planned Care and Insourcing.

 

Totally is committed to pursuing a progressive buy-and-build consolidation strategy within the fragmented healthcare market and looks to capitalise on the attractive opportunities that its disruptive service model offers, to generate value to shareholders.

 

Urgent Care

Totally offers a full range of urgent care services via its subsidiaries, Vocare and Greenbrook Healthcare, two of the largest urgent care providers in the UK, including:

 

·NHS 111 services

·Clinical Assessment services

·GP Out-of-Hours services

·Urgent Treatment Centres

 

www.vocare.org.uk

www.greenbrook.nhs.uk

 

Planned Care

Totally delivers planned care services, which include community based Out-Patient Services, Referral Management Services, Physiotherapy and Podiatry Services. It provides these through its planned care subsidiaries, About Health, Premier Physical Healthcare and Optimum Physiotherapy.

 

www.abouthealthgroup.com

www.premierphysicalhealthcare.co.uk

www.optimum-hcs.com

 

Insourcing

Launched in October 2019, Totally Healthcare provides bespoke insourcing solutions across multiple specialities to trusts and hospitals in the UK and Ireland, reducing waiting lists by utilising their spare capacity outside of normal working hours and weekends.

 

www.totallyhealthcarelimited.com

 

More information on Totally plc can be found at the following link: www.totallyplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKLLFFFZLFBBX
Date   Source Headline
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights
3rd Feb 20234:41 pmRNSExercise of options, director/PDMR & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.